Novo Nordisk lines up for May Alzheimer's trial

According to database Clinical Trials, Novo Nordisk will launch clinical trials for the company's diabetes drug semaglutide in tablet form as a possible treatment for Alzheimer's in end-May.

Photo: Novo Nordisk / PR

Read this article for free

Register with your E-mail.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

WS Audiology plans to list subsidiary

Privately-owned hearing aid company WS Audiology, which grew out of the merger between Widex and Sivantos, plans to list, which handles online sales.

Further reading

Related articles

Latest news

See all jobs